semaglutide contraindications What are the prerequisites and for initiating (generic: semaglutide) in a patient with type 2 diabetes or obesity? What are the contraindications to

According to FutureMarketInsights, the GLP-1 nutritional support market is forecast to reach USD 13 billion by 2035 , up from USD 4.1 billion in 2025 , advancing at a 12.2% CAGR

Cardiovascular benefits: Beyond their glucose-lowering effects, some GLP-1 agonists have demonstrated cardiovascular benefits in clinical trials, including a reduction in the risk of major cardiovascular events like heart attacks and strokes

Not identical in mechanism, but comparable in outcome, and with the safety net of a regulated supply chain

GLP-1 medications slow gastric emptying, which can change how quickly some oral drugs are absorbed, especially early in treatment and after dose increases

They achieve this by acting at the local level to repair ligaments, tendons, and gut tissues, while also promoting systemic healing through improved blood flow and muscle regeneration